SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $845,000 | -33.7% | 277,184 | +0.7% | 0.00% | -50.0% |
Q3 2016 | $1,275,000 | -20.2% | 275,389 | -0.2% | 0.00% | 0.0% |
Q2 2016 | $1,598,000 | +12.4% | 275,923 | +17.4% | 0.00% | 0.0% |
Q1 2016 | $1,422,000 | -32.7% | 235,000 | +1.5% | 0.00% | -33.3% |
Q4 2015 | $2,113,000 | +62.2% | 231,421 | +0.2% | 0.00% | +50.0% |
Q3 2015 | $1,303,000 | -49.9% | 231,058 | -1.4% | 0.00% | -33.3% |
Q2 2015 | $2,600,000 | -11.9% | 234,428 | +24.6% | 0.00% | -25.0% |
Q1 2015 | $2,950,000 | +4.9% | 188,129 | +1.7% | 0.00% | 0.0% |
Q4 2014 | $2,813,000 | +39.4% | 184,953 | -1.2% | 0.00% | +33.3% |
Q3 2014 | $2,018,000 | -28.9% | 187,138 | +0.7% | 0.00% | -25.0% |
Q2 2014 | $2,839,000 | -14.6% | 185,892 | +1.1% | 0.00% | -20.0% |
Q1 2014 | $3,325,000 | +43.5% | 183,894 | +10.2% | 0.01% | +66.7% |
Q4 2013 | $2,317,000 | +30.8% | 166,822 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $1,771,000 | +57.7% | 168,872 | +17.4% | 0.00% | +50.0% |
Q2 2013 | $1,123,000 | – | 143,835 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |